Bionime Corp (4737)

Currency in TWD
54.90
+0.10(+0.18%)
Closed·
4737 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.2056.20
52 wk Range
49.7579.00
Key Statistics
Bid/Ask
70.60 / 70.80
Prev. Close
62
Open
55.9
Day's Range
54.2-56.2
52 wk Range
49.75-79
Volume
79.5K
Average Volume (3m)
169.79K
1-Year Change
-26.4075%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4737 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Bionime Corp News & Analysis

Show more
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14/05/2026
EPS / Forecast
-1.09 / --
Revenue / Forecast
405.26M / --
EPS Revisions
Last 90 days

4737 Income Statement

Compare 4737 to Peers and Sector

Metrics to compare
4737
Peers
Sector
Relationship
P/E Ratio
−17.1x37.0x−0.5x
PEG Ratio
0.22−0.370.00
Price/Book
1.9x2.4x2.6x
Price / LTM Sales
2.4x2.5x3.0x
Upside (Analyst Target)
-46.5%58.6%
Fair Value Upside
Unlock21.5%10.2%Unlock

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. The company also provides wholesale medical devices, biotechnology services, pharmaceutical testing, and wholesale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.

Employees
500
Market
Taiwan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
462.94K0.69%25.37M
Other Institutional Investors
22.75M33.81%1.25B
Public Companies & Retail Investors
44.07M65.50%2.42B
Total
67.29M100.00%3.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Tonghua Dongbao Pharmaceutical Co., Ltd.19.62%13,198,277724,585
Hua Eng Wire & Cable Co., Ltd.11.45%7,704,384422,971

FAQ

What Is the Bionime (4737) Stock Price Today?

The Bionime stock price today is 54.90 TWD.

What Stock Exchange Does Bionime Trade On?

Bionime is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Bionime?

The stock symbol for Bionime is "4737."

What Is the Bionime Market Cap?

As of today, Bionime market cap is 4.24B TWD.

What Is Bionime's Earnings Per Share (TTM)?

The Bionime EPS (TTM) is -3.60.

When Is the Next Bionime Earnings Date?

Bionime will release its next earnings report on 18/08/2026.

From a Technical Analysis Perspective, Is 4737 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bionime Stock Split?

Bionime has split 3 times.

How Many Employees Does Bionime Have?

Bionime has 500 employees.

What is the current trading status of Bionime (4737)?

As of 12/06/2026, Bionime (4737) is trading at a price of 54.90 TWD, with a previous close of 62.00 TWD. The stock has fluctuated within a day range of 54.20 TWD to 56.20 TWD, while its 52-week range spans from 49.75 TWD to 79.00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.